A micro method to measure para-amino hippurate and creatinine in plasma and urine  by Baranowski, Robert L. & Westenfelder, Christof
Kidney International, Vol. 30 (1986), pp. 113—115
TECHNICAL NOTE
A micro method to measure para-amino hippurate and
creatinine in plasma and urine
ROBERT L. BARANOWSKI and CHRISTOF WESTENFELDER
Sec/ion of Nephrology, V.A. Medical Center and University of Utah, Salt Lake City. Utah, U.S.A.
The Bratton—Marshall method [I] or its slight modification [2,
3] is extensively used for photometric analysis of para-amino
hippurate (PAH) in biological fluids. It is more commonly
employed in renal clearance techniques to measure effective
renal plasma flow and tubular secretory rate [TmPAH] [2, 3].
There are many disadvantages to this method [1—4], including:
1) stepwise multiple reagent additions; 2) the intervals between
mixing must be carefully timed; and, 3) the nitrite and sulfamate
reagents are unstable. This procedure is complicated and time
consuming when numerous analyses are to be performed, as in
renal clearances. In this report, a rapid and reproducible micro
method for the simultaneous determination of PAH and creat-
mine in plasma is described, which employs a micropartition
system to remove proteins prior to high performance reverse
phase chromatographic analysis. This procedure takes into
account the plasma binding of PAH in each sample under all
experimental conditions. This technique has also been applied
to urine samples.
High performance liquid chromatographic (HPLC) analysis
was performed using a Beckman (Berkeley, California, USA) 5
.t Ultrasphere octadecyl silane (ODS) column (0.46 x 25 cm).
The pumping system was a Milton Roy mini-pump Model 396
(Riviera Beach, Florida, USA) operating at I ml/min, and the
samples were applied with a Rheodyne 7125 injection valve
(Cotati, California, USA) with a 20 .d sample loop. PAH and
creatinine were separated with a mobile phase consisting of a
98:2 (by volume) mixture of 0.05 M ammonium acetate (pH 6.0)
and acetonitrile. Absorbance at 236 nm was monitored in the
eluent with a Waters Model 481 (Milford, Massachusetts, [JSA)
variable wavelength detector set at 0.05 aufs.
Plasma (50 iii) was placed in a reservoir of an Amicon
(Danvers, Massachusetts) micropartition filtration unit and cen-
trifuged for 10 mm at 3,500 rpm (1,740 xg) (Sorvall, Dupont
Instruments, Newton, Connecticut, USA). Aliquots of the
filtrate were subjected to HPLC analysis. A blank plasma
sample (without PAH) was assayed to correct for interference.
PAH and creatinine peak height were measured and its concen-
tration determined with reference to a calibration curve.
Routinely, urine was diluted 1:50 in column buffer, vortex—
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mixed and submitted to HPLC analysis. A urine sample without
PAH was treated in a similar manner and served as the blank.
Recovery of PAH and creatinine from plasma and water after
the addition of an aliquot of standard to encompass the same
concentration range as for plasma was performed using the
micropartition system. Recovery from urine was also deter-
mined.
The chromatographic method was compared with the con-
ventional colorimetric method for PAH [2, 3] using ultrafiltered
plasma and urine samples. The chromatographic method was
also compared with the kinetic method for creatinine (Beckman
Instrument Co., Fullerton, California, USA) using untreated
plasma and urine.
Clearance experiments were performed in normal male
Sprague—Dawley rats (250 to 300 g) which had been instru-
mented as previously described [5]. The infusion of PAH and
1251-iothalamate was adjusted to obtain plasma concentrations
of PAM (2 to 5 mg/dl) to determine effective renal plasma flow
and sufficient activity of iothalamate to determine glomerular
filtration rate.
Discarded human plasma, originally obtained from azotemic
patients for routine clinical laboratory evaluation, was analyzed
by a kinetic (Beckman) and this HPLC method.
The applicability of reverse phase liquid chromatography to
separate and quantitate both creatinine and PAH in plasma and
urine is illustrated in Figures 1 and 2. The retention times of
creatinine and PAH are 4.08 and 4.44 mm, respectively. Typical
chromatograms obtained from HPLC analysis of blank rat
plasma and urine demonstrated no interferences at retention
times corresponding to standard PAH and creatinine. The two
peaks obtained from plasma and urine samples from rats that
had been infused with PAH had identical retention times for
both PAH and creatinine standards. Standard calibration
curves for PAH and creatinine are shown in Figure 3. They
demonstrate a linear relationship between peak height and the
amount of injected standard.
The ultrafiltration system used to separate PAH and creati-
nine from plasma proteins was rapid and gave reproducible
results. Neither PAH or creatinine were retained by the mem-
brane, and recovery was complete when the standards were
added to water and then ultrafiltered (Table 1). Recovery of
creatinine from plasma after ultrafiltration was virtually com-
plete (94.5% by HPLC and 95.5% by a kinetic method). The
recovery of PAH from plasma was 79.3% by HPLC and 81.0%
by the Bratton—Marshall method, indicating it was binding to
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Fig. 1. Chromatogram of PAH and creatinine in plasma. The
chromatogram in panel A does not contain PAH and is the blank. The
an-ow indicates the time of injection. The peaks for PAH and creatinine
(CR) are labeled.
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Fig. 2. Chromatogram of PAH and creatinine in urine. The
chromatograph in panel A does not contain PAH and is the blank. The
an-ow indicates the time of injection. The peaks for PAH and creatinine
(CR) are labeled.
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Fig. 3. Calibration curves for PAH and creatinine. The regression
equation is y = 0.910 l4.8x (r2 = 0.999) for PAH andy 0.9 + 88.4x(r2 = 0.999) for creatinine. Each data point is the mean of five or more
determinations SD and the solid line is the regression fit of the data.
Table 1. Recovery of PAH (3 mgldl) and creatinine (1.1 mg/dl) from
ultrafiltered normal rat plasma and water.
PAH concentration Creatinine concentration
Bratton
Marshall HPLC Kinetic HPLC
Plasma Plasma Water Plasma Plasma Waler
N
Mean
STD
% REC
11
2.43
0.10
81.0
11 13
2.38 2.99
0.09 0.10
79.3 99.7
10
1.05
0.05
95.5
16 8
1.04 1.15
0.05 0.04
94.5 104.5
plasma proteins. The recovery of PAH and creatinine from
urine was 100%, that is, complete.
Comparison of the HPLC method with a kinetic method for
the determination of creatinine in normal rat plasma and urine
gave identical results (Table 1 and Fig. 4) as did a comparison of
PAH values determined by either the HPLC or the Brat-
ton—Marshall method (Table 1 and Fig. 5).
Comparison of the HPLC method with a kinetic method for
the determination of creatinine in human plasma from azotemic
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patients gave identical results (Fig. 6). There was variability in
the amount of an unidentified compound present in plasma from
azotemic patients which had a retention time identical to PAH.
This interference would, however, not pose a problem if a PAR
clearance were to be performed in these patients, because
interference could be subtracted by analyzing a blank plasma
sample obtained prior to the infusion of PAR.
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Fig. 4. Urinary creatinine concentration determined by a kinetic
method versus the HPLC method described here. A total of 41 samples
were analyzed from 10 normal rats. The solid line is the line of identity.
Regression equation of the data is y = (—0.82) + 1.07X (r2 = 0.991).
Bratton—Marshall, mg/dl
Fig. 5. Urinary PAH concentration determined by the Brat-
ton—Marshall method versus the HPLC method. A total of 15 samples
were analyzed from 10 normal rats. The solid line is the line of identity.
Regression equation of the data is y (—68.3) + l.14x (r2 = 0.995).
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Fig. 6. Creatinine concentration of human plasma from azotemic
patients by a kinetic versus the HPLC method. A total of 16 samples
were analyzed. The solid line is the line of identity. Regression equation
of the data is y = (—0.43) + I .06x (r2 0.989).
simultaneously in small sample volumes (50 1.d), such as those
obtained in small animal clearance experiments. Additionally,
only unbound or free PAH is measured after ultrafiltration,
thereby taking into account any experimental alterations in
plasma binding. If greater sensitivity is required to measure
PAH in other biological fluids and when the simultaneous
determination of creatinine is not necessary, absorbance of
PAH can be monitored at 273 nm (absorption maximum).
Creatinine does not absorb at this wavelength.
We are currently using this method to analyze creatinine and
PAH in samples from all clearance experiments.
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This paper has described and validated a simple, rapid and
sensitive micromethod for the simultaneous determination of
PAH and creatinine in biological fluids. It is essentially a
modification of an HPLC method used previously to measure
only creatinine [61. The method incorporates ultrafiltration,
using a micropartition system to separate PAH and creatinine
from plasma proteins. Excellent reproducibility of retention
times and peak heights was obtained and thereby eliminated the
use of an internal standard. In order to take into account any
variation in peak height that may occur, a calibration curve was
obtained on each day of analysis.
Measurements of both PAN and creatinine are often desired
in renal function studies. Therefore, the utility of this method
resides in the fact that PAH and creatinine can be determined
